Stroke survivors may walk better with muscle retraining device
NCT ID NCT07041775
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a training method called MINT that helps stroke survivors reduce abnormal muscle co-activation in their legs. The goal is to improve walking speed and endurance. Researchers will enroll 72 adults who had a stroke at least 6 months ago and have moderate to severe walking problems. Participants will use a myoelectric interface to learn better muscle control.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- myoelectric interface for neurorehabilitation (MINT) conditioning
- What this could lead to
- If it works, this could lead to a new therapy that helps stroke survivors walk faster and farther by retraining muscle control.
- What could go wrong
- This is an early-stage study with only 72 participants, so results may not apply to everyone. The training is non-invasive but may not improve walking for all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Mar 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age at enrollment is 18 to 85 * Leg impairment from unilateral stroke at least 6 months prior to screening * Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m/s, i.e., half of normal speed) * Able to stand without assistance * Clinically observable gait asymmetry * Abnormal co-activation between adductor magnus and rectus femoris (R greater than or equal to 0.5) Exclusion Criteria: * Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task * Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games * Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games * Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment * Inability to understand or follow commands in English due to aphasia or other reason that makes it impossible to perform the training * Diffuse or multifocal infarcts * Substantial leg or other pain preventing participation for 60 minutes a day * Spasticity treatment (pharmacological or Botox) on the affected leg within past 3 months * Severe osteoporosis causing hip or other fractures * History of multiple falls within the last year, use of walker for balance, or falling during stance while in the lab in the first session. * Contracture limiting the range of motion of the leg * Current pregnancy * From the TMS portion of the study only: History of epilepsy in adulthood requiring antiseizure medications; recent/current alcoholism or benzodiazepine/barbiturate abuse or recent history of alcohol/benzodiazepine/barbiturate withdrawal, recent history of cocaine or amphetamine use, skull fractures or skull deficits, concussion within the last 6 months, unexplained recurring headaches, vagus nerve stimulator, cochlear implant, deep brain stimulator, intracranial/carotid stents, cardiac pacemaker/AICD.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
-
University of Texas Southwestern Medical Center
NOT_YET_RECRUITINGDallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robot could let stroke patients rehab their hands at home without a therapist
- Moving patterns may help stroke survivors read faster
- Vibrating wearables put stroke walking to the test
- Robot plus electrical stimulation aims to rebuild arm movement after stroke
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next